Teleflex (TFX) Hits New Lifetime High Today
Trade-Ideas LLC identified
(
) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Teleflex as such a stock due to the following factors:
- TFX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $57.3 million.
- TFX has traded 2,376 shares today.
- TFX is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in TFX with the Ticky from Trade-Ideas. See the FREE profile for TFX NOW at Trade-Ideas
More details on TFX:
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The stock currently has a dividend yield of 0.8%. TFX has a PE ratio of 34. Currently there are 7 analysts that rate Teleflex a buy, no analysts rate it a sell, and 3 rate it a hold.
The average volume for Teleflex has been 299,200 shares per day over the past 30 days. Teleflex has a market cap of $7.6 billion and is part of the health care sector and health services industry. The stock has a beta of 0.91 and a short float of 4.6% with 5.35 days to cover. Shares are up 34.9% year-to-date as of the close of trading on Thursday.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Analysis:
rates Teleflex as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, notable return on equity, reasonable valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
Highlights from the ratings report include:
- Powered by its strong earnings growth of 26.50% and other important driving factors, this stock has surged by 30.90% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, TFX should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
- TELEFLEX INC has improved earnings per share by 26.5% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, TELEFLEX INC increased its bottom line by earning $4.91 versus $4.09 in the prior year. This year, the market expects an improvement in earnings ($7.23 versus $4.91).
- The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, TELEFLEX INC's return on equity exceeds that of both the industry average and the S&P 500.
- Net operating cash flow has significantly increased by 61.78% to $66.71 million when compared to the same quarter last year. In addition, TELEFLEX INC has also vastly surpassed the industry average cash flow growth rate of -16.79%.
- You can view the full Teleflex Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.